Apeiron Investment Group Ltd. - Net Worth and Insider Trading
Apeiron Investment Group Ltd. Net Worth
The estimated net worth of Apeiron Investment Group Ltd. is at least $69 Million dollars as of 2024-05-08. Apeiron Investment Group Ltd. is the 10% Owner of ATAI Life Sciences NV and owns about 33,885,999 shares of ATAI Life Sciences NV (ATAI) stock worth over $69 Million. Apeiron Investment Group Ltd. is also the 10% Owner of Sensei Biotherapeutics Inc and owns about 0 shares of Sensei Biotherapeutics Inc (SNSE) stock worth over $0. Details can be seen in Apeiron Investment Group Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Apeiron Investment Group Ltd. has not made any transactions after 2023-06-01 and currently still holds the listed stock(s).
Transaction Summary of Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Apeiron Investment Group Ltd. owns 2 companies in total, including ATAI Life Sciences NV (ATAI) , and Sensei Biotherapeutics Inc (SNSE) .
Click here to see the complete history of Apeiron Investment Group Ltd.’s form 4 insider trades.
Insider Ownership Summary of Apeiron Investment Group Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATAI | ATAI Life Sciences NV | 2023-03-29 | 10 percent owner |
| SNSE | Sensei Biotherapeutics Inc | 2023-06-01 | 10 percent owner |
Apeiron Investment Group Ltd. Latest Holdings Summary
Apeiron Investment Group Ltd. currently owns a total of 2 stocks. Among these stocks, Apeiron Investment Group Ltd. owns 33,885,999 shares of ATAI Life Sciences NV (ATAI) as of March 29, 2023, with a value of $69 Million and a weighting of 100%. Apeiron Investment Group Ltd. also owns 0 shares of Sensei Biotherapeutics Inc (SNSE) as of June 1, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Apeiron Investment Group Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATAI | ATAI Life Sciences NV | 2023-03-29 | 33,885,999 | 2.03 | 68,619,148 |
| SNSE | Sensei Biotherapeutics Inc | 2023-06-01 | 0 | 1.78 | 0 |
Holding Weightings of Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Apeiron Investment Group Ltd. has made a total of 10 transactions in ATAI Life Sciences NV (ATAI) over the past 5 years, including 10 buys and 0 sells. The most-recent trade in ATAI Life Sciences NV is the acquisition of 1,214,297 shares on March 29, 2023, which cost Apeiron Investment Group Ltd. around $2 Million.
According to the SEC Form 4 filings, Apeiron Investment Group Ltd. has made a total of 2 transactions in Sensei Biotherapeutics Inc (SNSE) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Sensei Biotherapeutics Inc is the sale of 3,441,661 shares on June 1, 2023, which brought Apeiron Investment Group Ltd. around $5 Million.
Insider Trading History of Apeiron Investment Group Ltd.
- 1
Apeiron Investment Group Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Apeiron Investment Group Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Apeiron Investment Group Ltd. is -12.94%. GuruFocus also compares Apeiron Investment Group Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Apeiron Investment Group Ltd. within 3 months outperforms 1 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Apeiron Investment Group Ltd.'s insider trading performs compared to the benchmark.
Performance of Apeiron Investment Group Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.76 | | | | | |
| Relative Return to S&P 500(%) | -11.65 | | | | | |
Apeiron Investment Group Ltd. Ownership Network
Apeiron Investment Group Ltd. Owned Company Details
What does ATAI Life Sciences NV do?
Who are the key executives at ATAI Life Sciences NV?
Apeiron Investment Group Ltd. is the 10 percent owner of ATAI Life Sciences NV. Other key executives at ATAI Life Sciences NV include See Remarks Srinivas Rao , Chief Business Officer Sahil Kirpekar , and Chief Accounting Officer Anne Nagengast Johnson .
ATAI Life Sciences NV (ATAI) Insider Trades Summary
Over the past 18 months, Apeiron Investment Group Ltd. made 1 insider transaction in ATAI Life Sciences NV (ATAI) with a net purchase of 1,214,297. Other recent insider transactions involving ATAI Life Sciences NV (ATAI) include a net purchase of 130,000 shares made by Florian Brand , a net sale of 61,640 shares made by Srinivas Rao , and a net sale of 35,801 shares made by Sahil Kirpekar .
In summary, during the past 3 months, insiders sold 124,851 shares of ATAI Life Sciences NV (ATAI) in total and bought 0 shares, with a net sale of 124,851 shares. During the past 18 months, 124,851 shares of ATAI Life Sciences NV (ATAI) were sold and 1,344,297 shares were bought by its insiders, resulting in a net purchase of 1,219,446 shares.
ATAI Life Sciences NV (ATAI)'s detailed insider trading history can be found in Insider Trading Tracker table.
ATAI Life Sciences NV Insider Transactions
Apeiron Investment Group Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Apeiron Investment Group Ltd.. You might contact Apeiron Investment Group Ltd. via mailing address: Block A, Apt.12, Il-piazzetta, Tower Road, Sliema O1 Slm1605.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
